Ratings by Gabelli (Kevin Kendra)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/9/2021 | Assertio Therapeutics | ASRT | Upgrade | Buy (Hold) |
0.59 (0.79) |
33.9% | Details | |
| 12/17/2020 | Assertio Therapeutics | ASRT | Downgrade | Hold (Buy) |
0.38 (0.79) |
107.89% | Details | |
| 2/6/2020 | Phibro Animal Health Corp. | PAHC | Downgrade | Hold (Buy) |
27.72 (12.44) |
-55.12% | Details | |
| 11/11/2019 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2019 | Teva Pharma | TEVA | Upgrade | Buy (Hold) |
6.97 (13.25) |
90.1% | Details | |
| 5/10/2019 | Melinta Therapeutics Inc. | MLNT | Downgrade | Sell (Buy) |
4.63 (0.50) |
-89.2% | Details | |
| 5/9/2019 | Phibro Animal Health Corp. | PAHC | Upgrade | Buy (Hold) |
28.99 (12.44) |
-57.09% | Details |
